Noninvasive assessment of liver fibrosis: Key messages for clinicians

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 6, 2014, Pages 329-335

  Caviglia, Gian P ^a   Touscoz, Giovanni A ^b   Smedile, Antonina ^a   Pellicano, Rinaldo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Chronic liver disease; Liver biopsy; Liver fibrosis; Noninvasive fibrosis assessment

Indexed keywords

BIOLOGICAL MARKER;

CHRONIC LIVER DISEASE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; ELASTOGRAPHY; FIBROGENESIS; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SEROLOGY; BIOPSY; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; LIVER; PATHOLOGY; PATHOPHYSIOLOGY;

BIOMARKERS; BIOPSY; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; LIVER; LIVER CIRRHOSIS;

EID: 84906806481     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2301     Document Type: Review

References (50)

1. Van Gulick JJ, Lamers MH, Drenth JP. Hepatitis C virus infection management in 2012. Panminerva Med. 2012; 54: 1-9.
2. Kosmalski M, Kasznicki J, Drzewoski J. Relationship between ultrasound features od nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes. Pol Arch Med Wewn. 2013; 123: 436-442.
3. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997; 349: 825-832. (Pubitemid 27129209)
4. Castera L. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C. Minerva Gastroenterol Dietol. 2006; 52: 125-134. (Pubitemid 43774322)
5. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008; 371: 838-851. (Pubitemid 351323895)
6. Berrutti M, Ciancio A, Smedile A, et al. Assessment of liver fibrosis in the clinical setting: something is changing? Minerva Gastroenterol Dietol. 2007; 53: 111-114. (Pubitemid 46975319)
7. Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol. 2006; 12: 3682-3694. (Pubitemid 43950946)
8. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1: 431-435. (Pubitemid 12218164)
9. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22: 696-699.
10. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994; 20: 15-20.
11. Attallah AM, El-Far M, Omran MM, et al. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients. J Clin Lab Anal. 2013; 27: 121-129.
12. Actis GC, Olivero A, Lagget M, et al. The practice of percutaneous liver biopsy in a gastrohepatology day hospital: a retrospective study on 835 biopsies. Dig Dis Sci. 2007; 52: 2576-2579. (Pubitemid 47373909)
13. Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007; 14: 360-369. (Pubitemid 46587854)
14. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003; 38: 1449-1457. (Pubitemid 37466971)
15. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003; 39: 239-244. (Pubitemid 36920560)
16. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002; 97: 2614-2618.
17. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol. 2003; 38: S38-53.
18. Baranova A, Lal P, Birerdinc A, et al. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 2011; 11: 91.
19. Caviglia GP, Ciancio A, Rosso C, et al. Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment. Ann Hepatol. 2014; 13: 91-97.
20. Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol. 2011; 25: 291-303.
21. Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis. 2006; 15: 149-159. (Pubitemid 44011767)
22. Wnuk Z, Kokot F, Kunsdorf-Wnuk A. Diagnostic value of plasma asymmetric and symmetric dimethylarginine levels in liver transplant recipients. Pol Arch Med Wewn. 2012; 122: 367-373.
23. Forns X, Ampurdanès S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002; 36: 986-992.
24. Becker L, Salameh W, Sferruzza A, et al. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastroenterol Hepatol. 2009; 7: 696-701.
25. Parkes J, Roderick P, Harris S, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut. 2010; 59: 1245-1251.
26. Martínez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011; 53: 325-335.
27. Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Ann Intern Med. 2013; 158: 807-820.
28. Ahmad W, Ijaz B, Gull S, et al. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virol J. 2011; 8: 53.
29. Faria SC, Ganesan K, Mwangi I, et al. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009; 29: 1615-1635.
30. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003; 29: 1705-1713. (Pubitemid 38091720)
31. Ganne-Carrié N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006; 44: 1511-1517. (Pubitemid 44953656)
32. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006; 55: 403-408. (Pubitemid 43268281)
33. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005; 41: 48-54. (Pubitemid 40066382)
34. Talwalkar JA, Kurtz DM, Schoenleber SJ, et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007; 5: 1214-1220. (Pubitemid 47488974)
35. Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011; 54: 64-71.
36. Lim SG, Cho SW, Lee YC, et al. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. Hepatogastroenterology. 2011; 58: 539-545.
37. Wong GL, Wong VW, Choi PC, et al. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther. 2011; 16: 165-172.
38. Kim BK, Fung J, Yuen MF, Kim SU. Clinical application of liver measurement using transient elastography in chronic liver disease from longitudinal perpsectives. World J Gastroenterol. 2013; 19: 1890-1900.
39. Kim JE, Lee JY, Bae KS, et al. Acoustic radiation force impulse elastography for focal hepatic tumors: usefulness for differentiating hemangiomas from malignant tumors. Korean J Radiol. 2013; 14: 743-753.
40. Friedrich-Rust M, Nierhoff J, Lupsor M, et al. Performance of Acoustic Radiation Force Impulse-Imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat. 2012; 19: 212-219.
41. Sporea I, Badea R, Sirli R, et al. How efficient is acoustic radiation force impulse elastography for the evaluation of liver stiffness? Hepat Month. 2011; 11: 532-538.
42. Fiorini E, Cipriano V, De Molo C, et al. Real-time elastography as a non-invasive technique for quantification of fibrosis in patients with chronic viral liver disease: Preliminary findings. J Ultrasound. 2012; 15: 220-225.
43. Colombo S, Buonocore M, Del Poggio A, et al. Head-to-head comparison of transient elastography (TE), real time-tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis. J Gastroenterol. 2012; 46: 461-469.
44. Ronot M, Asselah T, Paradis V, et al. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology. 2010; 256: 135-142.
45. Romero-Gómez M, Gómez-González E, Madrazo A, et al. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology. 2008; 47: 810-816. (Pubitemid 351449672)
46. Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging. 2013; 37: 544-555.
47. Talwalkar JA, Yin M, Fidler JL, et al. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology. 2008; 47: 332-342. (Pubitemid 351171070)
48. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007; 5: 1207-1213.
49. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology. 2008; 135: 32-40. (Pubitemid 351899024)
50. Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR AM J Roentgenol. 2009; 193: 14-27.